008930.KS Hanmi Science Co., Ltd.
KSCHealthcareAs of 2026-08-09 03:18
Why 008930.KS matters now
Hanmi Science Co., Ltd. (008930.KS) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩44,650.00 with +1.94% on the session and ₩3.05T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 20.40, gross margin 15.3%, and operating margin 11.8%.
Valuation
P/E (TTM)
20.40
PEG
—
P/B
3.05
P/S
2.15
EV/EBITDA
23.39
DCF Value
—
FCF Yield
1.3%
Div Yield
0.7%
Margins & Returns
Gross Margin
15.3%
Operating Margin
11.8%
Net Margin
10.7%
ROE
16.0%
ROA
10.1%
ROIC
11.5%
Listing Info
Market
Korea
Exchange
KSC
Currency
KRW
Sector
Healthcare
Industry
Medical - Distribution
Country
KR
Hanmi Science Co., Ltd. operates through its subsidiaries to produce and distribute pharmaceutical products both within South Korea and internationally. The company's research and development initiatives primarily target treatments for diabetes and various types of cancer. Its extensive product line further includes active pharmaceutical ingredients, general therapeutic drugs, nutritional supplements, and a variety of health-related goods and services. Additionally, it manages an online pharmacy platform and provides automated systems for pharmaceutical administration. The firm, which was initially established as Hanmi Holdings Co., Ltd. in 1973, adopted its current name, Hanmi Science Co., Ltd., in March 2012, and its corporate headquarters are situated in Seoul, South Korea.